ArticleOPEN ACCESS

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Blood
DOI: 10.1182/blood-2018-02-832360
92Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Ciurea, S. O., Chilkulwar, A., Saliba, R. M., Chen, J., Rondon, G., Patel, K. P., … Champlin, R. E. (2018, June 28). Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2018-02-832360

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free